LCD Visual Chart

GUDID 06971922130066

Used to detect visual sensitivity, refractive properties and binocular vision of human eye.

Chongqing Yeasn Science & Technology Co.,Ltd.

Visual acuity projector
Primary Device ID06971922130066
NIH Device Record Key3ed93374-5261-4b3b-957b-2d4346eb2ec9
Commercial Distribution StatusIn Commercial Distribution
Brand NameLCD Visual Chart
Version Model NumberYPB-2100
Company DUNS547954649
Company NameChongqing Yeasn Science & Technology Co.,Ltd.
Device Count1
DM Exemptfalse
Pre-market Exempttrue
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numberfalse
Manufacturing Datefalse
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS106971922130066 [Primary]

FDA Product Code

HOXChart, Visual Acuity

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2020-10-30
Device Publish Date2020-10-22

Devices Manufactured by Chongqing Yeasn Science & Technology Co.,Ltd.

06971922136037 - YEASN2024-08-29 The eye refractometer measures the objective refractive errors (including spherical, cylindrical refractive errors, cylinder axi
06971922131292 - YEASN2024-08-16
06971922132244 - YEASN2024-08-16 For checking the refractive state of human eye.
06971922132763 - YEASN2024-08-16 This instrument is applicable with stand and projection for precision measurement of visual functions such as myopia, hyperopia,
06971922133234 - YEASN2024-08-16
06971922136525 - YEASN2024-08-16 Eye refractometer is an electrically-powered, ophthalmic device designed to be used by an optometrist to objectively measure the
06971922135030 - YEASN2022-08-04 For eye examination and aid in the diagnosis. Contraindications: none. Target groups of patients: adults, children. Intended use
06971922131070 - YEASN2022-04-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.